Andrographis (AP Extract).

The standardised Scandinavian preparation pairs andrographis with eleuthero, and much of the clinical record for andrographis was built on that combination. Eleuthero contributes the adaptive side while andrographolide carries the immune signalling.

Echinacea alkylamides act on cannabinoid receptor 2 on immune cells, while andrographolide works through NF-kappaB signalling. Two different upstream levers on the same response.

Elderberry anthocyanins act at the level of viral entry and cytokine balance, a different point from andrographolide's transcriptional effect. Seasonal formulas routinely carry both.

Zinc is required for thymulin activity and for normal T-cell development, and its status limits how well an immune response can be mounted. Andrographis modulates signalling but supplies no cofactor.

Neutrophils concentrate ascorbate many times over plasma levels and consume it during the respiratory burst. That demand sits alongside, not inside, andrographis's signalling effect.

Piperine slows intestinal and hepatic glucuronidation, the main clearance route for andrographolide. Blood levels of the diterpene run higher and longer as a result.

Andrographolide reduces platelet aggregation, and EPA shifts eicosanoid balance towards less aggregatory thromboxane. Taken together the effect on normal clotting is additive.

Ginkgolide B antagonises platelet activating factor, a separate route to the same endpoint andrographolide reaches. The two overlap on normal platelet function.

Garlic organosulfur compounds reduce platelet aggregation through thromboxane synthesis. Combined with andrographis the effect on normal clotting stacks.

Both are cleared largely by glucuronidation in the liver and gut wall. Co-dosing shifts the pace at which each is conjugated and cleared.

AP is the standardised andrographolide-bearing extract of the same plant. Combining a standardised extract with a whole-herb powder stacks the same diterpene.

Andrographolide and curcumin are both lipophilic, poorly soluble and heavily conjugated on first pass. They are commonly built into the same lipid or phospholipid delivery systems for that reason. The pairing is a formulation logic and a shared metabolic route rather than a measured combined effect.

Ginger and Andrographis appear together in traditional preparations, and both undergo extensive glucuronidation and sulfation. Stacking them loads the same conjugation capacity. The pairing is customary rather than trial-tested.

Licorice is used in traditional formulas to make bitter herbs palatable and is frequently paired with Andrographis on that basis. The rationale is sensory and traditional. Licorice carries its own considerations at higher intakes, notably its effect on potassium and blood pressure, so the pairing is not free of consequence.

Astragalus and Andrographis are conventional partners in traditional formulation practice for seasonal immune support. Neither the combination nor a shared mechanism has been mapped in controlled human work. The row records the formulation convention, not an effect.

Reishi contributes beta-glucans and triterpenes while Andrographis contributes diterpenoid lactones, so the two are chemically distinct inputs to the same product concept. Combination data does not exist. This is formulation convention.

Cordyceps and Andrographis are routinely combined in seasonal-support formulas. The actives are unrelated and no interaction is described. The pairing is convention, and the row exists so it is not mistaken for a tested synergy.

Turkey tail supplies polysaccharide fractions and Andrographis supplies andrographolide, two chemically separate inputs. Products combine them for breadth of the ingredient list. No combination study exists.

Propolis and Andrographis extract turn up together in throat sprays and lozenges. The rationale is category convention and complementary sensory profile. Nothing has been measured about the pair.

Quercetin is a well-described inhibitor and substrate of UDP-glucuronosyltransferases, and andrographolide is cleared largely by sulfation and glucuronidation. Co-dosing plausibly raises unconjugated andrographolide exposure. The direction is mechanistic and has not been quantified for this pair, so read it as a reason to keep doses conservative rather than as a delivery strategy.

EGCG competes for sulfotransferase and glucuronosyltransferase capacity, the same routes that clear andrographolide. Concentrated extracts of both have been associated with liver enzyme changes in case reports of their own, so stacking two concentrated extracts is a decision to make deliberately. Liver enzymes are markers, not outcomes.

The alpha,beta-unsaturated lactone of andrographolide is a Michael acceptor and forms adducts with cysteine thiols, which is how much of its cellular activity is described. Adding a large thiol load from NAC changes the pool that chemistry meets. The direction of the net effect is not established, so the row is mechanistic.

Silymarin components inhibit UGT and some CYP isoforms in vitro, which overlaps the clearance route of andrographolide. Products combine them anyway on category logic. Read the pairing as a pharmacokinetic caution to check rather than as a benefit.

Boswellic acids and andrographolide are both poorly water-soluble and both absorb better from a fat-containing meal or a lipid vehicle. They are often placed in the same softgel for that reason. The shared constraint is real; a combined effect has not been measured.

Bromelain is included in botanical formulas on the argument that it improves uptake of co-administered actives. Evidence for that specific role with andrographolide does not exist. The row records the practice and its limit.

Poorly water-soluble diterpenoid lactones dissolve into a medium-chain triglyceride phase, which keeps them in solution through gastric transit instead of precipitating. This is standard lipid-vehicle formulation for lipophilic botanicals. It changes delivery, not the intrinsic activity of the molecule.

Phospholipid complexation gives a lipophilic plant active an amphiphilic surface, so it disperses in gut fluid rather than sitting undissolved. The approach is used across the poorly soluble botanicals and applies to andrographolide on the same chemistry. It is a delivery decision.

Complexing a lipophilic plant active with phosphatidylcholine is the established phytosome approach to solubility-limited absorption. Andrographolide meets the criteria for that approach. The complex changes dissolution behaviour rather than the molecule itself.

Nitrate from beetroot raises nitric oxide availability and modestly lowers blood pressure in human trials, and andrographolide shows a hypotensive direction in animal studies. Two inputs pointing the same way are worth declaring for anyone already managing blood pressure with medication. The animal data does not carry to humans on its own.

Berberine lowers fasting glucose in human trials and andrographolide lowers it in rodent models. Stacked, the direction is additive and matters most for anyone already using glucose-lowering medication. The andrographolide side is preclinical and should not be read as a human finding.

Gymnema and Andrographis both appear in blood-sugar-support blends and both carry a glucose-lowering direction in the available work. The additive point is one to declare for people on medication. Neither the combination nor the size of the combined effect has been measured.

Cinnamon extract shows small fasting glucose reductions in pooled human data and andrographolide shows the same direction in animals. The combination is a stacking caution rather than a benefit claim. Report it as additive direction, not as an established combined effect.

Both point toward reduced clot formation from different directions, one on platelets and one on fibrin. Anyone on anticoagulant or antiplatelet medication should have that combination on the record. The evidence is preclinical on both sides of this pairing.

Concentrated bitter botanical extracts show broad antimicrobial activity in laboratory assays, and that activity does not distinguish supplemented strains from resident ones. Separating dosing times is the conventional handling. Whether this matters at supplement doses in a real gut has not been measured.

Vitamin D acts through a nuclear receptor and its own hydroxylation cascade, entirely separate from andrographolide chemistry. Products combine them for category breadth. The row exists to note there is no interaction, only co-formulation.